FAM119A Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-56655
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Synthetic peptides corresponding to FAM119A(family with sequence similarity 119, member A) The peptide sequence was selected from the N terminal of FAM119A.
Peptide sequence ALVPYEETTEFGLQKFHKPLATFSFANHTIQIRQDWRHLGVAAVVWDAAI. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for FAM119A Antibody
Western Blot: FAM119A Antibody [NBP1-56655]
Western Blot: FAM119A Antibody [NBP1-56655] - Human Brain lysate, concentration 0.2-1 ug/ml.Applications for FAM119A Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: FAM119A
Alternate Names
EC 2.1.1.-, FAM119A, HCA557B, Hepatocellular carcinoma-associated antigen 557b, hypothetical protein LOC151194, LOC151194, member A, methyltransferase like 21A, MGC45373
Gene Symbol
METTL21A
UniProt
Additional FAM119A Products
Product Documents for FAM119A Antibody
Product Specific Notices for FAM119A Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...